$MDXL MediXall Group, Inc. -- October 14, 2020 -- Health

New Post Public Reply Private Reply Replies (0) Message Board
budfoxfun
99
$MDXL MediXall Group, Inc. -- October 14, 2020 -- Health Karma is selected by one of New York's largest brokerage firms with over 800 agents.

Fort Lauderdale, FL, Oct. 14, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- MediXall Group Inc. (OTCQB: MDXL), a technology and innovation-driven organization focused on reducing healthcare costs and transforming the patient-provider experience through the launch of its Health Karma™ platform, is excited to announce that Oxford Property Group, one of New York's largest brokerage firms with over 800 agents, has selected Health Karma to help their agents better engage and navigate their healthcare through personalized insights.

With this announcement, Health Karma will be launching its platform to employers, small businesses, and other organizations to give their employees and members access to all of their healthcare and benefits information in one place, with an easy-to-use, personalized experience that can help guide them to better health decisions. Health Karma will leverage this partnership to work with more employers in the coming months.



Co-founder and CEO of Oxford Property Group, Adam Mahfouda, set out to create the real estate company he wished existed. With a background in residential rentals and sales, he knew that finding a new home could be frustrating for clients and how to make it better. Over 3,000 transactions and 800 agents later, Oxford Property Group has grown into the place that Adam always wanted it to be, providing an essential service that's the best in NYC.

“At Oxford, we use our unique real estate expertise and market intelligence to develop innovative, tailored solutions that help our clients succeed,” said Adam Mahfouda. “Health Karma gives us the chance to further extend this same philosophy to our own agents -- we have always wanted to provide our agents with health benefits, so we see this as an affordable way for Oxford to provide them with greater access to care and the information they need to make the best and most cost-effective healthcare decisions for them, which is vital at a time like this.”

Oxford agents can think of Health Karma as their personal hub for all things health and wellness. The Company is on a mission to deliver the healthcare experience everyone deserves. From choosing a doctor and managing bills to understanding benefits, Oxford agents can actively and confidently manage their healthcare anywhere, anytime, whether they have insurance or not.

In just a couple of taps on the Health Karma app, Oxford employees can:

Talk to a Doctor Virtually 24/7/365

Find a Healthcare Provider or Facility

Track and Review Current Plan Usage - All in Real-Time

Personalized Cost Estimates

Find Rx Savings

Send Medical Records

“We are proud to work with Oxford, a nationally recognized leader in real estate who is equally committed to the same level of excellence when it comes to investing in their agents by providing them with the tools and solutions needed to succeed,” said Michael Swartz, President of Health Karma. “With the Health Karma platform, Oxford is empowering its agents to make the most of their healthcare, including accessing the right programs, care and providers for themselves and families.”

As the New York City market continues to evolve, so does Oxford. Now with over 800+ agents, Oxford is one of the largest real estate firms in New York City. Having Health Karma and Oxford joining forces will only expand on the values they both share which is innovation, iteration and giving people the resources they need to thrive.

Oxford equips their agents with the resources and access to everything they need to close deals, over and over again. They have the latest technology and software so that they can focus on what really matters: their clients. This partnership will enable Oxford to provide a solution to their agents to help them manage their entire healthcare process while giving them a more complete picture of their healthcare by bringing everything together.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 1

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 3

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 1

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 12

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
ATTACK SHARK Partners with Cloud9 League Team

Updated Category News Views 2

Shaking Hands with Cloud9 ATTACK SHARK is jumping headfirst into the esports game, teaming up with Cloud9's League of Legends team. Now, before you roll your eyes at another corporate matchmaking play, consider the magic at play here. League of Legends isn't just any game; it's a titan in the esports universe, and partnering with Cloud9 offers a serious boost. It's not...

Continue Reading
Zendure, SolarFlow Pro Win Big at IFA 2026 Tech Awards

Updated Category News Views 2

Trophy Time for Zendure in Berlin The Berlin Chronicles of 2026 tell an interesting tale for Zendure—a tale where top honors and glowing recognition highlight its efforts in the sustainable energy arena. At the Global Product Technology Innovation Awards, Zendure's SolarFlow 4000 Mix Pro snagged the Gold for Sustainable Home Energy Storage System. Not only that, but...

Continue Reading
Media Forum Spotlights Asia-Pacific Cooperation

Updated Category News Views 3

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

Continue Reading
Fosun Pharma Hits the Buyback Button: What's Next?

Updated Category News Views 0

Fosun Pharma's Bold Move Well, if this isn't Fosun Pharma making some noise! Announcing an H-share repurchase plan worth up to HK$1 billion is like setting off fireworks amidst any investor's evening. They're hollering to the market, 'We see value, and we're doubling down on it.' Crunching the Numbers In the first half of 2026, Fosun Pharma's numbers weren't just a flash...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 3

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading

Top 5 Most Recently Viewed Articles

Prologis Earnings Report: Investors' Key Insights and Analysis

Updated Category News Views 138

Understanding Prologis's Upcoming Quarterly Earnings Prologis (NYSE: PLD) is set to release its latest quarterly earnings report, and investors are eagerly awaiting the insights it will provide. As the company approaches its earnings announcement, analysts project an earnings per share (EPS) of $1.02, which serves as a benchmark for performance expectations. Investor...

Continue Reading
How Changing U.S. Jobs Report Affects Market Dynamics

Updated Category News Views 171

The recent U. S. employment report sent shockwaves through financial markets, reshaping how traders and investors eyed their portfolios. Stronger-than-expected job creation—with figures soaring over 100,000—meant one thing: the narrative on interest rates was about to change. Gone were the days of comfortably betting on rate cuts; now, everyone’s scrambling to...

Continue Reading
Suno Boosts Innovation for Creators by Acquiring WavTool

Updated Category News Views 157

Suno Boosts Innovation for Creators by Acquiring WavTool Suno has recently made a significant move in the music industry with their acquisition of WavTool. This strategic decision aims to enhance their offerings for songwriters and producers, enabling them to create music that resonates with a broader audience. By integrating WavTool's advanced capabilities into their...

Continue Reading
Leqembi's New IV Treatment Approval: A Milestone for Alzheimer’s Care

Updated Category News Views 274

Leqembi Approved for IV Maintenance Treatment BioArctic AB, a notable player in the biopharmaceutical sector, has made significant headlines with the approval of Leqembi (lecanemab) for intravenous (IV) maintenance treatment for Alzheimer’s disease in the United Kingdom. This groundbreaking decision was announced following rigorous evaluations by the Medicines and...

Continue Reading
Investors of ATYR, MLTX, BAX, and JHX Have Legal Options

Updated Category News Views 145

Overview of Class Action Lawsuits for ATYR, MLTX, BAX, JHX Attention investors! If you’ve invested in aTyr Pharma Inc. (NASDAQ: ATYR), MoonLake Immunotherapeutics (NASDAQ: MLTX), Baxter International, Inc. (NYSE: BAX), or James Hardie Industries plc (NYSE: JHX), it’s important to be aware of significant class action lawsuits affecting your investments. These companies...

Continue Reading